This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.

Discover the Latest in Research Peptides at Biotech Labz Supply Sebastopol, United States - January 3, 2026 / Biotech ...

Excellergy has been snapped up by the Swiss pharma only five months after emerging with $70 million in funds. The Palo Alto, ...

Federal health officials issued a warning Tuesday over misleading statements made by biotech billionaire Dr. Patrick ...

Techcyte has been named 2025 Infectious Disease Testing Solution of the Year by the BioTech Breakthrough Awards, a leading ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

Attend or sponsor our commercial real estate event in San Francisco: Bay Area Life Sciences & Biotech Conference.

The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

March 27 (Reuters) - Swiss drugmaker Novartis said on Friday it will buy California-based biotech company Excellergy in a ...